The U.S. International Trade Commission recently released a 500-page report exploring the complex nexus of intellectual property, COVID-19, and access to essential drugs and tests. Despite the extensive analysis, the report notably refrains from drawing a definitive conclusion, leaving policymakers to navigate the nuanced terrain of innovation and public health. Read more…
In a letter addressed to Congress, and organized by Competitive Enterprise Institute, the undersigned organizations express their strong concerns regarding the Inflation Reduction Act (IRA), particularly its provisions related to prescription drug price controls. The coalition argues that the IRA’s prescription drug price control regime is unnecessary, as it focuses Read more…
President Biden’s populist approach to healthcare reform, focusing on price controls, has stirred controversy in the pharmaceutical industry. A new article by Market Institute President Charles Sauer in The Hill highlights the potential consequences of this strategy, including drug shortages and stifled innovation. By exploring the lessons learned from Japan’s Read more…
Just over a year ago, President Biden aimed to lead the nation towards innovation and collaboration, promoting research and unity to solve one of modern life’s biggest challenges—cancer. The United States has a long history of innovation, driven by a patent system that protects inventors and encourages investment in research Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Markets on a bill recently introduced in Congress called the PREVAIL Act. If passed, it will help level the playing field for inventors, most notably by attempting to fix the Patent Trial and Appeals Board. He writes: Read more…
The Market Institute President Charles Sauer has a new article in The Washington Examiner’s Restoring America series on whether Congress is ready to finally pull the plug on the patent killing Patent Trial and Appeal Board. He writes: “We all know the basic plot of gladiator-style movies : The underdog battles in Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Markets arguing the important of patents to the American economy. Innovation will undoubtedly suffer in this country if patents are weakened. He writes: “While many rights in the Constitution are defined vaguely, the Founders laid out one Read more…
The Market Institute President Charles Sauer has a new article in the Washington Examiner’s Restoring America series looking at why Senator Patrick Leahy (D-VT) is ending his tenure in the Senate with a patent bill that will harm inventors. “The 47-year-serving Democratic senator from Vermont, Patrick Leahy, is finishing his Read more…
The Market Institute President Charles Sauer has submitted the following statement to Senate Committee on the Judiciary, Subcommittee on Intellectual Property for the Hearing on The Patent Trial and Appeal Board: Examining Proposals to Address Predictability, Certainty, and Fairness. June 22, 2022 The Market Institute advocates on behalf of small Read more…
The Market Institute President Charles Sauer has a new piece in the Washington Examiner’s Restoring America series on Standard Essential Patents. Excerpt below. “Sometimes, in Washington, D.C., it’s hard to figure out which side is the good side and which is the bad. It’s not an old Western film in Read more…